Aktuellt
SENASTE
Bactiguard reported Q4 net sales of SEK 63m (SEB at SEK 57m) with organic net sales growth of 12% y/y (SEBe: -3% y/y). License revenues is the main explanation for the Q4 beat but also somewhat higher contribution from the BIP portfolio that is being phased out. Q4 EBITDA was SEK 8m (SEB at SEK 1m). Bactiguard says it will revert no later than the end of Q1/25 with new financial targets. Small positive revisions warranted.
LÄS MER
